Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors

Summary

This study assesses the safety and efficacy of imatinib mesylate treatment of patients with malignant peripheral nerve sheath tumors

Timeline

Start

2006-05

Primary completion

2009-04

Completion

—

Outcome

Outcome not reported

Stopped (Enrollment): “stopped due to slow recruitment and no effect”

Drugs

Indications